# A First-In-Human Study of the Study Medicine, Called PF-07291177, in Healthy Adult Participants

> **NCT05434091** · PHASE1 · WITHDRAWN · sponsor: **Pfizer**

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** PF-07291177
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05434091
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-08-15
- **Primary completion:** 2023-03-29
- **Final completion:** 2023-03-29
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study stopped due to change in strategy.
- **Last updated:** 2022-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05434091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05434091, "A First-In-Human Study of the Study Medicine, Called PF-07291177, in Healthy Adult Participants". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05434091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*